相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Considerations for rare variants in drug metabolism genes and the clinical implications
Britt I. Droegemoeller et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver
Wanqing Liu et al.
HUMAN MOLECULAR GENETICS (2014)
Pharmacogenomic implications of population admixture: Brazil as a model case
Guilherme Suarez-Kurtz et al.
PHARMACOGENOMICS (2014)
Effect of human glutathione S-transferase hGSTP1-1 polymorphism on the detoxification of reactive metabolites of clozapine, diclofenac and acetaminophen
Sanja Dragovic et al.
TOXICOLOGY LETTERS (2014)
Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen
Eun-Jin Kim et al.
ASIA PACIFIC ALLERGY (2014)
Candidate Gene Polymorphisms in Patients with Acetaminophen-Induced Acute Liver Failure
Michael H. Court et al.
DRUG METABOLISM AND DISPOSITION (2014)
Xenobiotic Metabolizing Cytochrome P450 in Pig, a Promising Animal Model
Emanuela Puccinelli et al.
CURRENT DRUG METABOLISM (2013)
Acetaminophen and asthma
A. John Henderson et al.
PAEDIATRIC RESPIRATORY REVIEWS (2013)
Chronic Acetaminophen Exposure in Pediatric Acute Liver Failure
Mike A. Leonis et al.
PEDIATRICS (2013)
Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis
Mitchell R. McGill et al.
PHARMACEUTICAL RESEARCH (2013)
3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Patrina Gunness et al.
TOXICOLOGICAL SCIENCES (2013)
The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
Michael H. Court et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo
Kathrin Klein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Comparison of tolerability and efficacy of a combination of paracetamol plus caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
Luigi Alberto Pini et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases
Abd-Rahman Marzilawati et al.
BMC PHARMACOLOGY & TOXICOLOGY (2012)
Impact of the Interaction between 3′-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes
Rongrong Wei et al.
Frontiers in Genetics (2012)
Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma
Seif O. Shaheen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Genetic Predictors of Interindividual Variability in Hepatic CYP3A4 Expression
Vishal Lamba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort
Matthew S. Perzanowski et al.
THORAX (2010)
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
Alison H. Harrill et al.
GENOME RESEARCH (2009)
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium
Luigi Alberto Pini et al.
JOURNAL OF HEADACHE AND PAIN (2008)
Mapping the genetic architecture of gene expression in human liver
Eric E. Schadt et al.
PLOS BIOLOGY (2008)
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1l2 and their association with CYP3A4 expression
Jatinder Lamba et al.
DRUG METABOLISM AND DISPOSITION (2008)
Human SULT1A1 gene:: copy number differences and functional implications
Scott J. Hebbring et al.
HUMAN MOLECULAR GENETICS (2007)
Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver
ZB Duanmu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Comparative genomics analysis of human sequence variation in the UGT1A gene cluster
ML Maitland et al.
PHARMACOGENOMICS JOURNAL (2006)
Updates on acetaminophen toxicity
AK Rowden et al.
MEDICAL CLINICS OF NORTH AMERICA (2005)
Symptomatic treatment of migraine in children: A systematic review of medication trials
L Damen et al.
PEDIATRICS (2005)
UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics:: I.: Identification of polymorphisms in the 5′-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation
S Krishnaswamy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S)
S Krishnaswamy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects
JAJH Critchley et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
The CYP2E1-humanized transgenic mouse:: Role of CYP2E1 in acetaminophen hepatotoxicity
C Cheung et al.
DRUG METABOLISM AND DISPOSITION (2005)
Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1
FJ Gonzalez
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Human hepatic CYP2E1 expression during development
EK Johnsrud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Paracetamol and metabolite pharmacokinetics in infants
CD van der Marel et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Reduction of toxic metabolite formation of acetaminophen
E Hazai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Developmental aspects of human hepatic drug glucuronidation in young children and adults
CP Strassburg et al.
GUT (2002)
The genetic determinants of the CYP3A5 polymorphism
E Hustert et al.
PHARMACOGENETICS (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
分享论文
